Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Janus kinase inhibitors (JAKi) belong to a new class of oral targeted disease-modifying
drugs which have recently revolutionized the therapeutic panorama of rheumatoid arthritis …

Only a minority of rheumatoid arthritis (RA) patients achieve disease remission, so the
exploration of additional pathogenic factors and the development of new therapeutics are …

Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The
American Pain Society and the American Academy of Pain Medicine commissioned a …

Objective To compare tumor necrosis factor α inhibitors directly regarding the rates of
treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis …

Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of
subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in …

Flavonoids are natural polyphenolic compounds which are included in a panoply of drugs
and used to treat and/or manage human ailments such as metabolic, cardiovascular …

The sol-gel synthesized NiO nanoparticles were characterized and used for the modification
of a carbon paste electrode (CPE) in electrocatalytic voltammetric determination of …

Objectives To review the evidence for the efficacy and safety of biological agents in patients
with rheumatoid arthritis (RA) to provide data to develop treatment recommendations by the …

Objective There is a need for comparative studies to provide evidence‐based treatment
guidance for biologic agents in rheumatoid arthritis (RA). Therefore, this study was …